Biotech and Pharmaceuticals Medicine

  • Dec 5- Pfizer Inc said on Monday its cancer drug, Bosulif, was found effective in a late-stage study on previously untreated patients with a form of blood and bone marrow cancer that is characterized by the abnormal production of white blood cells. Most people with chronic myeloid leukemia have a genetic mutation, called the Philadelphia chromosome, which...

  • ZURICH, Dec 5- Roche's Gazyva cancer drug did not show a significant overall survival benefit and raised greater safety concerns than its predecessor Rituxan, a study showed, raising doubts over the Swiss pharmaceuticals group's bid to replace a key blockbuster. An analysis released at the weekend meeting of the American Society of Hematology found that for...

  • Dec 3- An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form of blood cancer in 82 percent of children and young adults treated with modified immune cells in a mid-stage trial, the company said on Saturday. The trial results were presented at a meeting of the American Society of Hematology in San Diego.

  • Dec 2- A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology, where clinical trial results will help clarify their potential for doctors and investors. "Juno has dug themselves into such a deep hole," said Brad Loncar, manager of the Loncar Cancer Immunotherapy ETF.

  • Dec 2- A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology, where clinical trial results will help clarify their potential for doctors and investors. "Juno has dug themselves into such a deep hole," said Brad Loncar, manager of the Loncar Cancer Immunotherapy ETF.

  • Jardiance, a once-daily pill also known as empagliflozin, was approved by the FDA in 2014 to help lower blood sugar in patients with type 2 diabetes. At the time of approval the FDA asked that a separate trial be conducted to show the drug did not increase the risk of cardiovascular problems. Jardiance belongs to a new family of treatments called SGLT2 inhibitors...

  • Dec 2- The U. S Food and Drug Administration said on Friday it would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces the risk of death from heart problems, potentially boosting the drug's sales. Jardiance, also known as empagliflozin, was approved by the FDA in 2014 to help lower blood sugar in patients with type 2 diabetes.

  • Dec 2- The U. S Food and Drug Administration said on Friday it had approved Eli Lilly and Co and Boehringer Ingelheim Pharmaceuticals Inc's drug, Jardiance, to reduce the risk of cardiovascular death in patients with type 2 diabetes. The risk of death from heart disease is 70 percent higher in diabetics compared to those without diabetes, according to the U.S....

  • BRIEF-GSK APPLIES FOR EU MARKETING NOD FOR COPD DRUG COCKTAIL@. *Gsk files regulatory submission in european union for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD. *Regulatory submissions of closed triple therapy for COPD are anticipated in rest of world beginning in 2017.

  • BRIEF-GSK'S LUNG DRUG GAINS APPROVAL IN JAPAN@. *Relvar Ellipta 100/ 25 mcg gains approval in Japan for use in patients with COPD. *Relvar Ellipta has been approved in Japan for treatment of asthma since 2013 in two strengths- 100/ 25 mcg and 200/ 25 mcg.

  • Jill Teeters with her husband, Dave, and son, Aidan

    Scientists are taking a new approach to the riddle of preterm birth, which kills 1 million babies globally each year.

  • Bluebird Bio CEO on new study data: We're getting profound responses

    CNBC's Meg Tirrell speaks with Bluebird Bio CEO Nick Leschly about his company's successful study of its multiple myeloma treatment as well as the election effect on the biotech sector.

  • But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases. Fauci hopped on a plane to Cambridge, Mass., to personally tell Japan's Takeda Pharmaceutical Co's U.S. representatives that their drug...

  • Nov 30- Pfizer Inc said on Wednesday its experimental biosimilar of Roche Holding AG's blockbuster breast cancer treatment Herceptin was found comparable with the branded version in a key study. Unlike generic drugs, which are interchangeable with their branded counterparts, biosimilars approved by the U.S. Food and Drug Administration to date are not...

  • Nov 30- Pfizer Inc said on Wednesday its experimental biosimilar of Roche Holding AG's blockbuster breast cancer treatment Herceptin met the main goal in a key study. Pfizer tested the safety and effectiveness of the drug, PF-05280014, in combination with chemotherapeutic agent paclitaxel against Herceptin and paclitaxel in previously untreated...

  • Escherichia coli bacteria in a colored electron-scanning micrograph

    Everyone from government to independent foundations are funding microbiome research. Why bacteria's DNA is garnering so much attention.

  • Nov 29- U.S. biotech Momenta Pharmaceuticals Inc said on Tuesday its experimental biosimilar version of AbbVie Inc's top-selling autoimmune drug, Humira, met the main goal in a late-stage trial involving patients with a form of psoriasis. Humira, considered the world's biggest-selling medicine, generates $15 billion in annual sales and treats rheumatoid...

  • *GSK to start large trials testing protective injection. LONDON, Nov 29- Scientists are taking the battle to prevent HIV to the next level with large-scale trials set to start using injections to protect vulnerable groups such as gay men and women in Africa for at least two months. Some women in trials in Africa, for example, said they were reluctant to have HIV...

  • SEOUL, Nov 29- South Korea will cull 3 percent of its total poultry population to curb an outbreak of bird flu that has hit a number of farms across the nation, its agriculture ministry said on Tuesday. Despite the efforts, Korea's Ministry of Agriculture, Food and Rural Affairs said in a statement on Tuesday that four new cases of H5N6 had been confirmed in central...

  • *Says company had 240 mln euros in cash end-Sept. PARIS, Nov 25- France's Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent for the time being and will seek co-development deals modeled on an agreement struck with AstraZeneca in April. In August Pfizer announced the $14 billion...